Switching Therapies, Managing Adverse Effects, and Adherence Challenges

Panelists discuss how therapy switching is often required to optimize outcomes, especially when adverse effects compromise adherence or efficacy wanes over time.

Panelists discuss how neurologic, metabolic, and cardiovascular adverse effects demand vigilant management to prevent treatment discontinuation.

Panelists discuss how adherence remains a linchpin of success, with behavioral and digital interventions offering promising tools to support patient engagement.